Mani Foroohar

Mani Foroohar

Analyst-Equity bei
Leerink Partners LLC
Finance
Consumer Services

Profil

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A. from Columbia, and a B.S.
from UCLA.

Aktive Positionen von Mani Foroohar

UnternehmenPositionBeginn
Analyst-Equity 01.05.2018

Ehemalige bekannte Positionen von Mani Foroohar

UnternehmenPositionEnde
Analyst-Equity 01.12.2014
Analyst-Equity -
Sehen Sie sich die Erfahrung von Mani Foroohar im Detail an

Ausbildung von Mani Foroohar

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

99

Beziehungen ersten Grades

6

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen6

Finance

Finance

Consumer Services

Finance

Consumer Services

Consumer Services

  1. Börse
  2. Insiders
  3. Mani Foroohar